🏠 Study Hub 🖼️ Infographics
Nursing Field Notes / Pharmacology Β· Antihypertensives Β· Adrenergic Blocking Drugs

ABC πŸ…°οΈ

Alpha Β· Beta Β· Central β€” the adrenergic-blocking map, and the PERIPHERALLY ACTING half of it

NG-013 PHARM Β· Cardio ADHD-friendly visual edition

ABC is how the antihypertensive adrenergic blockers get sorted: Alpha, Beta, Central. The whole family turns down the sympathetic "fight-or-flight" signal β€” the only question on the exam is WHERE the drug turns it down. Peripherally acting = out at the nerve ending / receptor in the body, inhibiting norepinephrine in the PNS β†’ treats HTN + BPH. Centrally acting = up in the brain, decreasing CNS sympathetic activity β†’ treats HTN.

📄 Simple Nursing original — opens in Drive →

πŸ—ΊοΈ Location is the answerPeripheral = nerve ending & vessel/prostate receptor. Central = brainstem. Same signal, two addresses.
🚽 Peripheral treats TWO thingsHTN + BPH β€” same alpha-1 receptor lives in the vessel wall and the prostate.
πŸͺ‘ First dose = floor doseOrthostatic hypotension & syncope. Give the first dose at bedtime, rise slowly forever after.
🚫 Withdrawal phenomenonNever stop abruptly β€” rebound hypertension. Taper, always.
πŸ’Š

WHAT IT DOES

STEP 1 Β· WHERE IT ACTS

One sympathetic signal, two places to cut it: in the brain before it's sent, or in the body where it lands.

πŸ—ΊοΈ The ABC map β€” Alpha, Beta, Central

EXAM TIP Every drug in this family is an adrenergic blocking drug (an antiadrenergic). They all end the same way β€” vasodilation and a lower blood pressure. They differ only in which point of the sympathetic pathway they interrupt.

🧠 C = CENTRALLY ACTING clonidine Β· methyldopa β€” cut the order before it is sent Cerebellum Vasomotor center Ξ±2 receptors live here brainstem / medulla Rx Clonidine Methyldopa stimulate Ξ±2 β†’ less outflow sent Spinal cord sympathetic outflow signal travels out ⟢ 🎯 A/B = PERIPHERALLY ACTING doxazosin Β· prazosin β€” block the signal where it lands Sympathetic nerve ending releases norepinephrine (NE) NE Smooth muscle Arteriole wall in cross-section β€” lumen in the middle Ξ±1 receptor Rx Doxazosin Β· Prazosin sit on the Ξ±1 receptor β€” NE arrives but can't bind Vessel relaxes lumen widens Β· BP falls Same Ξ±1 receptor sits in the PROSTATE β†’ that is why one drug treats HTN and BPH

Left panel: the drug never lets the order leave the brainstem. Right panel: the order is sent, but the doorbell is taped over.

🧠 "C is for Cranium." Central drugs work in the Cranium (clonidine, methyldopa β€” both start with a soft C sound). Alpha blockers work Away from the brain β€” out at the Arteriole and the prostate. If the stem says "decreases CNS activity" β†’ central. If it says "inhibits norepinephrine in the PNS" β†’ peripheral.

πŸ’Š The four prototype drugs β€” memorize this grid

GenericTrade Central / PeripheralTypical starting doseRoute
ClonidineCatapresCENTRAL 🧠0.1 mg (100 mcg) BIDPO, transdermal patch
Methyldopaβ€”CENTRAL 🧠250–500 mg 2–3Γ—/dayPO
DoxazosinCardura, Cardura XLPERIPHERAL 🎯1 mg once dailyPO
PrazosinMinipressPERIPHERAL 🎯1 mg 2–3Γ— dailyPO

Notice both peripheral drugs start at 1 mg and both end in -osin. Notice both central drugs are the odd, old-fashioned names.

🧠 "-OSIN means OUTSIDE." Doxazosin, prazosin, tamsulosin β€” the -osin ending marks the peripheral alpha-1 blockers. Everything not ending in -osin on this page is central.

⭐ Why do we give it? β€” the indications

  • 🩸 Hypertension (HTN) β€” both halves of the family
  • 🚽 BPH (benign prostatic hyperplasia) β€” peripheral only; relaxes prostate/bladder-neck smooth muscle so urine flows
  • πŸ’“ Certain cardiac arrhythmias

EXAM TIP If a male client is on an -osin drug, ask which problem you're treating β€” the same tablet can be prescribed for the blood pressure OR the urine stream.

🧠 "Peripheral = Pressure + Pee." Two P's for the peripheral half. Central only gets the first P.

🎯 Alpha-1 blockade in the prostate β€” the BPH half

🚫 Ξ±1 STIMULATED muscle squeezes Β· urethra pinched bladder Weak stream Β· retention hesitancy Β· dribbling Β· nocturia urethra βœ… Ξ±1 BLOCKED muscle relaxes Β· urethra opens Rx Free flow πŸ’§ less retention Β· less nocturia

Same alpha-1 receptor, different organ: block it in the vessel and pressure drops; block it in the prostate and the stream opens.

🧠 "Relax the gate, let the water out." The prostate wraps the urethra like a fist. Alpha-1 blockade opens the fist.
⚠️

WATCH FOR

STEP 2 Β· ADVERSE EFFECTS

Turn the sympathetic system down and everything it normally keeps "up" sags β€” pressure, pulse, gut motility, saliva, tears, erections.

🚨 Adverse effects β€” organized by body system

πŸ‘οΈ EENT dry eyes πŸ‘„ GI dry mouth Β· constipation nausea Β· vomiting πŸ’“ CARDIOVASCULAR AV block Β· bradycardia hypotension (esp. with epidural) palpitations 🚻 GU erectile dysfunction …yes, the same class that treats BPH can cause ED. Ask, don't assume. 🧴 DERM rash Β· sweating πŸ§ͺ FLUID & ELECTROLYTE sodium retention hyperkalemia (↑ K⁺) βš–οΈ METABOLIC weight gain 🧠 NEURO paresthesia (pins & needles) πŸ” MISC WITHDRAWAL PHENOMENON stop it suddenly β†’ rebound HTN
🧠 "Everything DRIES, everything SLOWS, everything SAGS." Dries = eyes & mouth. Slows = heart rate, AV conduction, bowel. Sags = blood pressure and erections. Then add the two lab words the source calls out: sodium retention and hyperkalemia.

πŸͺ‘ First-dose / orthostatic hypotension β€” the fall risk

πŸ“‰ STAND UP β†’ PRESSURE FALLS Lying flat BP normal πŸ™‚ πŸ’« dizzy Standing vessels can't clamp β†’ syncope HIGH LOW BP drops on standing

Give the first dose at bedtime and stay with the client on the first ambulation. Sit 1 min, stand 1 min, then walk.

🧠 "First dose, floor dose." The very first tablet is the one that puts them on the floor.

πŸ’Š Interactions the nurse must question

Add this……and you get
Adrenergics (sympathomimetics)Risk of hypertension β€” they push the exact system we're blocking
LevodopaHypotension + decreased levodopa effect
Anesthetic agentsIncreased anesthetic effect β€” flag before surgery
Beta blockersHypertension (rebound risk, especially if clonidine is stopped while the beta blocker continues)
LithiumLithium toxicity πŸ§ͺ
HaloperidolPsychotic behavior reported
🧠 "A-L-A-B-L-H" β†’ Adrenergics Β· Levodopa Β· Anesthetics Β· Beta blockers Β· Lithium Β· Haloperidol. Say it as "A LAB, LH" β€” picture a lab tech named LH holding all six bottles.

🚫 Contraindications β€” they split by central vs peripheral

🧠 CENTRALLY acting β€” do NOT give with🎯 PERIPHERALLY acting β€” do NOT give with
Active hepatic (liver) disease β€” methyldopa is hepatotoxic
MAOI antidepressant therapy β€” dangerous BP swings
Ulcerative colitis
Peptic ulcer disease β€” the older peripheral agents increase GI secretion & motility

Plus the universal ones: known hypersensitivity, and caution in any client already on another sympatholytic or with an existing cardiac conduction problem.

🧠 "Central hits the LIVER, peripheral hits the GUT." C = liver + MAOI. P = colitis + ulcer.
πŸ—£οΈ

TEACH & MONITOR

STEP 3 Β· NURSING MANAGEMENT

Everything here is straight nursing-management scoring: measure it, weigh it, taper it, and never trim the patch.

βœ… The monitoring ladder β€” in the order you'd actually do it

1
BP & pulse BEFORE the first dose β€” then frequently during initial dose adjustment and every increase, then periodically throughout therapy.
β–Ό
2
Intake & output ratios + DAILY WEIGHT β€” these drugs cause sodium retention. 1 kg = 1 L of fluid.
β–Ό
3
Assess for edema daily β€” especially at the beginning of therapy. Check dependent areas: ankles, sacrum in a bedbound client.
β–Ό
4
Titrate SLOWLY in clients with cardiac conditions or on other sympatholytic drugs β€” and report significant changes.
🧠 "BIER" β€” BP & pulse Β· Intake/output Β· Edema daily Β· Report changes. Picture a stein of bier on the scale: fluid you have to weigh every morning.

🩹 Transdermal clonidine β€” the patch rules

🩹 PATCH β†’ SKIN β†’ BLOODSTREAM backing (never cut!) drug reservoir rate membrane adhesive Epidermis Dermis Subcutaneous β€” capillary picks the drug up
  • βœ‚οΈ Do NOT cut or trim the unit β€” cutting destroys the rate-controlling membrane and dumps the dose.
  • 🚿 May stay on during bathing or swimming.
  • πŸ”„ Rotate sites; apply to clean, dry, hairless intact skin.
🧠 "Trim it = dump it." A trimmed patch is a broken dam.

❌ Withdrawal phenomenon β€” the never rule

πŸ’Š Client on clonidine for months
β–Ό
🚫 Runs out / "I felt fine so I stopped"
β–Ό
πŸ“ˆ Sympathetic system rebounds, unopposed
β–Ό
🚨 REBOUND HYPERTENSION β€” severe BP spike, headache, agitation, tachycardia

Never stop an adrenergic blocker abruptly. Taper on a schedule; teach the client to refill before the last tablet.

🧠 "The brake pedal you can't just lift." These drugs hold the sympathetic brake down. Lift your foot suddenly and the car lurches forward β€” that lurch is rebound HTN.

πŸ†š Don't mix up the three "peripheral" mechanisms

MechanismExample drugsWhat actually happens
Presynaptic NE-release blockerreserpine, guanethidine-classNE is never released from the nerve ending (see NG-260)
Postsynaptic Ξ±1 blockerdoxazosin, prazosin, tamsulosinNE releases normally but can't bind β€” this page (depth in NG-141)
Central Ξ±2 agonistclonidine, methyldopaBrainstem sends less sympathetic outflow in the first place

All three are antiadrenergic. All three drop BP. Only the middle one also treats BPH.

🧠 Supply · Door · Order. Presynaptic cuts the supply. α1 blocker locks the door. Central cancels the order.
⚑

QUICK RECALL

SAY IT OUT LOUD
🎯 Peripheral= inhibits NE in the PNS β†’ treats HTN + BPH Β· doxazosin, prazosin
🧠 Central= decreases CNS activity β†’ treats HTN Β· clonidine, methyldopa
πŸͺ‘ Orthostatic= first dose at bedtime, rise slowly, fall precautions
🚫 Never abrupt stop= withdrawal phenomenon β†’ rebound HTN Β· never cut the patch
🎯 Cover & check β€” 5 rapid-fire questions
Q1: What does "peripherally acting" mean in one sentence?
It inhibits norepinephrine in the peripheral nervous system β€” at the nerve ending or at the alpha-1 receptor on the target tissue β€” so the vessel (and the prostate) relaxes. Indications: HTN and BPH.
Q2: Which half of the family is contraindicated in active hepatic disease and with MAOI therapy?
The CENTRALLY acting half (clonidine, methyldopa). The peripherally acting agents are the ones flagged for ulcerative colitis and peptic ulcer.
Q3: A client's clonidine patch is "too big." Can you trim it?
Never. Do not cut or trim a transdermal unit β€” it destroys the rate-controlling membrane. Call the provider for a different strength. The patch may stay on during bathing or swimming.
Q4: Two electrolyte/fluid problems to monitor on this class?
Sodium retention (monitor I&O ratios, daily weight, daily edema assessment) and hyperkalemia.
Q5: Name three drugs that interact and what they cause.
Any three of: adrenergics β†’ hypertension; levodopa β†’ hypotension & decreased levodopa effect; anesthetic agents β†’ increased anesthetic effect; beta blockers β†’ hypertension; lithium β†’ lithium toxicity; haloperidol β†’ psychotic behavior.